The Patent Finder
US

1,2,4-Oxadiazole Derivatives as Immunomodulators

US 11,512,060 In force
OverviewFamilyAssignmentsSources & methods

Term ends Sep 5, 2034 · High confidence

Filed Mar 4, 2021 as application 17/192,279 · Granted Nov 29, 2022
Base term, 20 years from filing
Today
20 years from filing
2014 2034
Clock starts
Sep 5, 2014
Term ends
Sep 5, 2034
Granted
Nov 29, 2022
base term fee events Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,173,989, US 10,590,093, US 10,961,205, US 11,136,300, US 11,497,734, US 11,497,735, US 9,771,338, to Sep 5, 2034. The term already ends on or before that date, so the cap shortened nothing.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
8
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 2 maintenance fees is paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Sep 5, 2014, when application 14/478,759, the earliest non-provisional in its chain, was filed (this one was filed Mar 4, 2021)Sep 5, 2034High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,173,989, US 10,590,093, US 10,961,205, US 11,136,300, US 11,497,734, US 11,497,735, US 9,771,338)resolves to Sep 5, 2034, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 2 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderSep 5, 2034High confidence

This family

Application 14/478,759Abandoned
not computed
not computed
US 9,771,338In force
Sep 2034
Sep 2034
US 10,173,989In force
Sep 2034
Sep 2034
US 10,590,093In force
Sep 2034
Sep 2034
US 10,961,205In force
Sep 2034
Sep 2034
US 11,512,060this patent
Sep 2034
Sep 2034
US 12,037,321In force
no later than Sep 2034
no later than Sep 2034
US 12,643,870In force
Sep 2034
Sep 2034
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
May 16, 2023
Reel 63654, frame 411
Aurigene Discovery Technologies LimitedAurigene Oncology LimitedChange of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited